Nex-I, Inc.

  • Biotech or pharma, therapeutic R&D

NEX-I is an emerging company with groundbreaking ideas to propose next-gen immuno-oncology technology introducing a new paradigm in cancer therapy with a series of new target ONCOKINE(on smrt 이야기할것), that induces cancer cells to become resistant to the current therapy.

Address

South Korea

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS